Valsynthese is a Contract Development and Manufacturing Organization (CDMO) based in Brig, Switzerland, that provides high-quality services to its worldwide network.

Since its founding in 1983, the company has evolved into a premium provider of development and production services and a specialist in handling hazardous chemical reactions. Its approach involves its customers throughout the process, from development to scale-up, in constant cooperation. Beginning with tailor made and accurate propositions for specific projects, Valsynthese applies a custom-fit project management approach for every customer.

In this conversation with Contract Pharma, Dr. Max Lauwiner, CEO of Valsynthese, highlights the organization’s agility and emphasizes how the CDMO’s small size enables close, transparent and technically driven collaboration. He also addresses broader industry themes such as navigating geopolitical, logistical and quality risks.

Contract Pharma: What advantages do small CDMOs offer compared to larger, global organizations when supporting early-stage or innovative programs?

Max Lauwiner: Small CDMOs can offer a level of agility, proximity and senior technical attention that is particularly valuable for early-stage or innovative programs. At this stage, projects often…